News | News By Subject | News by Disease News By Date | Search News

Women's Health (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AMAG (AMAG) to Hire 150 New Sales Reps to Support New Drug Intrarosa     2/17/2017
Boston's Juniper Pharma (JNP) Terminates Development of Lidocaine Bioadhesive Gel After Phase II Trial Failure     8/18/2016
Drugmakers Like AbbVie (ABBV), Bayer (BAY) Turn Their Eyes to Women’s Health and a Disease With $78 Billion Cost Draws     8/4/2016
SAGE Therapeutics (SAGE)' Stock Explodes as Drug Eliminates Postpartum Depression in Mid-Stage Study     7/14/2016
Repros Therapeutics (RPRX) to Ditch Efforts to Seek Approval of Testosterone Drug in the U.S. if Key Study Fails     4/15/2016
Repros Therapeutics (RPRX) Skyrockets Premarket Following Positive Clinical Data for Vaginal Proellex     4/13/2016
Newly Named Millendo Therapeutics Snags $62 Million in Venture Funding and Buys AstraZeneca PLC (AZN) Drug     1/6/2016
Cara Therapeutics, Inc. (CARA) Soars 35% on Positive Phase II Uremic Pruritus Data     7/23/2015
TherapeuticsMD, Inc.  (TXMD) Has "Multiple Catalysts" in 2015/16 As Products Develop, Says Cowen and Company     2/26/2015
Novel Agreement Expands Access To Pfizer (PFE)'s Contraceptive, Sayana® Press, For Women Most In Need In The World’s Poorest Countries     11/17/2014
FDA Green Lights Starpharma Holdings Ltd's VivaGel Trial Design     7/14/2014
Umecrine Mood's Premenstrual Dysphoric Disorder (PMDD) Drug Fails Phase 2 Study     6/12/2014
Struggling Trimel Pharmaceuticals (Formerly Known As Trimel BioPharma) (TRL.TO)'s Sexual Disorder Drug Tefina™ Delivers In Mid-Stage Study     5/30/2014
Viamet Pharmaceuticals Reports Positive Interim Results Of Phase 2 Study Of VT-1161     2/19/2014
Sprout Pharmaceuticals's Female Libido Drug Gets No Love From The FDA, Company Plans To Appeal     12/13/2013

News from Around the Web
Scalp Cooling Device May Help Reduce Hair Loss For Women With Breast Cancer On Chemotherapy, JAMA Reveals     2/15/2017
Shift Work, Heavy Lifting May Reduce A Woman’s Fertility, Harvard Reveals     2/8/2017
Women's Health Biotech ObsEva (OBSV) to Open Up U.S. HQ in Boston After $97 Million IPO     1/30/2017
Can Strong Magnetics Revive Your Sex Drive? UCLA Study     1/5/2017
Lawsuit: Valeant (VRX) Is Letting "Female Viagra" Sales Sag     1/3/2017
More Men Are Developing Eating Disorders. Why Are We Treating It As Only A Women’s Disease?     12/28/2016
French Add To U.S. Concerns About Bayer (BAY) Contraceptive Implant     12/13/2016
Cancer Drug Helps Women Produce New Eggs, University of Edinburgh Study     12/7/2016
Why SCYNEXIS, Inc. (SCYX) Is Making A Run     10/7/2016
Botox Beats Implant For Urinary Incontinence In Women, Duke University Study     10/6/2016
Will The "Femtech" Revolution Really Offer A "Digital Contraceptive" And Detect Diseases Through A Phone?     9/20/2016
Quick Menstrual Cycle Linked To Lower Fertility, Boston University Study Reveals     9/6/2016
Is Sex In Later Years Good For Your Health? Michigan State University Study     9/6/2016
Feeling Heavy, Light, Or About Right? Your Genes May Be To Blame, University of Colorado Study     9/1/2016
Stress May Be Harder On Women's Hearts Than On Men's, Emory University Study Finds     8/26/2016

Press Releases
New Data In Nature's Scientific Reports Shows Natrol, Inc.' ADAPT Platform Detects Breast Cancer In Women Via Liquid Biopsy Of Circulating Exosomes     2/21/2017
Scalp Cooling Device May Help Reduce Hair Loss For Women With Breast Cancer On Chemotherapy, JAMA Reveals     2/15/2017
Easton Pharmaceuticals (OP: EAPH) And BMV Medica Announces First Shipment Of Gynofit To Multi-National Pharmaceutical Company, Gedeon Richter (RIG2.F), Towards Its Purchase Order, Has Been Received For February 16th Product Launch In Puerto Vallarta, Mexico     2/3/2017
Repros Therapeutics (RPRX) Release: FDA Grants End Of Phase 2 Meeting To Discuss Phase 3 Requirements For Oral Proellex In The Treatment Of Uterine Fibroids     1/31/2017
Myovant Release: Initiates Phase 3 Clinical Program Of Relugolix In Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids     1/25/2017
Symbiomix Release: Pharma Submits New Drug Application To US FDA For Solosec For The Treatment Of BV     1/19/2017
Allergan (AGN), Gedeon Richter (RIG2.F) Release: Companies Show Off Late-Stage Uterine Fibroids Data     1/17/2017
Palatin Tech (PTN) Release: Company To Hold Call Following Closing Of Licensing Agreement For North American Rights To Rekynda     1/11/2017
Ogeda Announces Positive Data From Phase IIa Trial Of Fezolinetant (ESN364) In The Treatment Of Menopausal Hot Flashes     1/4/2017
Karolinska Development AB Portfolio Company Dilafor Initiates Phase IIb Clinical Trial With Tafoxiparin In Women With Protracted Labor     1/4/2017
Mylan (MYL) Launches Generic Zovia Tablets     12/29/2016
Repros Therapeutics (RPRX) Requests Meeting With FDA To Discuss Phase III Requirements For Proellex In The Treatment Of Symptomatic Uterine Fibroids     12/13/2016
Allergan (AGN) Release: FIBRISTAL, The First And Only Medication Indicated For Uterine Fibroids, Receives Approval From Health Canada For Long Term Intermittent Treatment     11/21/2016
Matinas BioPharma Initiates Enrollment And Commences Patient Dosing In Phase II Study Of MAT2203 For The Treatment Of Vulvovaginal Candidiasis     11/21/2016
Repros Therapeutics (RPRX) Reports Topline Positive Clinical Data After Two 18 Week Courses Of Proellex Delivered Orally And Vaginally For The Treatment Of Uterine Fibroids     11/15/2016

//-->